Wanjia Group Holdings (HKG:0401) expects to record up to HK$1.5 million in profit attributable to owners for the six months ended Sept. 30, rebounding from a loss of HK$3.0 million a year ago.

The pharmaceutical distribution company attributed the turnaround to improvements in its hemodialysis treatment and consultancy service business segments in China, according to a Wednesday disclosure with the Hong Kong Exchange.